Pat Beyer - 29 Oct 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
President Int'l & Global Ortho
Signature
/s/ Sarah M. Oliker for Pat Beyer by Power of Attorney
Issuer symbol
CNMD
Transactions as of
29 Oct 2021
Net transactions value
-$8,075,751
Form type
4
Filing time
02 Nov 2021, 16:59:12 UTC
Previous filing
18 May 2021
Next filing
05 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $2,204,811 +55,300 +708% $39.87 63,107 29 Oct 2021 Direct
transaction CNMD Common Stock Tax liability $4,341,203 -30,018 -48% $144.62 33,089 29 Oct 2021 Direct
transaction CNMD Common Stock Sale $403,002 -2,789 -8.4% $144.50 30,300 29 Oct 2021 Direct F1
transaction CNMD Common Stock Sale $2,456,270 -16,904 -56% $145.31 13,396 29 Oct 2021 Direct F2
transaction CNMD Common Stock Sale $816,749 -5,589 -42% $146.14 7,807 29 Oct 2021 Direct F3
transaction CNMD Common Stock Options Exercise $2,600,910 +50,700 +649% $51.30 58,507 29 Oct 2021 Direct
transaction CNMD Common Stock Tax liability $4,864,249 -33,253 -57% $146.28 25,254 29 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -55,300 -100% $0.000000* 0 29 Oct 2021 Common Stock 55,300 $39.87 Direct F4
transaction CNMD Sars (Stock Appreciation Rights) Options Exercise $0 -50,700 -100% $0.000000* 0 29 Oct 2021 Common Stock 50,700 $51.30 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5 The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period.